Ignite Creation Date:
2024-05-06 @ 6:20 PM
Last Modification Date:
2024-10-26 @ 2:45 PM
Study NCT ID:
NCT05622591
Status:
WITHDRAWN
Last Update Posted:
2023-12-08
First Post:
2022-11-08
Brief Title:
ELU001 in Pediatric Subjects Who Have Relapsed andor Refractory CBFA2T3-GLIS2-positive AML
Sponsor:
Elucida Oncology
Organization:
Elucida Oncology
Organization Data
Organization:
Elucida Oncology
Class:
INDUSTRY
Study ID:
ELU-FRĪ±-AML-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Elucida Oncology
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None